Home/Filings/4/0001492647-26-000001
4//SEC Filing

Almenoff June Sherie 4

Accession 0001492647-26-000001

CIK 0000034956other

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 8:29 PM ET

Size

11.3 KB

Accession

0001492647-26-000001

Insider Transaction Report

Form 4
Period: 2026-01-09
Transactions
  • Award

    Stock Option (right to buy)

    2026-01-09+30,00030,000 total
    Exercise: $13.30From: 2027-01-09Exp: 2036-01-09Common Stock (30,000 underlying)
Holdings
  • Common Stock

    [F1]
    (indirect: By LLC)
    1,993
  • Stock Option (right to buy)

    Exercise: $3200.00From: 2022-06-10Exp: 2031-06-10Common Stock (4 underlying)
    4
  • Stock Option (right to buy)

    Exercise: $992.00From: 2023-06-09Exp: 2032-06-09Common Stock (4 underlying)
    4
  • Stock Option (right to buy)

    Exercise: $5.94From: 2025-12-10Exp: 2034-12-10Common Stock (100,000 underlying)
    100,000
  • Stock Option (right to buy)

    Exercise: $5.75From: 2026-07-01Exp: 2035-07-01Common Stock (80,000 underlying)
    80,000
Footnotes (1)
  • [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact|2026-01-13

Issuer

TENAX THERAPEUTICS, INC.

CIK 0000034956

Entity typeother

Related Parties

1
  • filerCIK 0001492647

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 8:29 PM ET
Size
11.3 KB